Loading
A randomised study of how the amount of information people get about multi-cancer blood tests changes their decisions.
Dartmouth randomised vignette trial on multi-cancer test information (NCT07793539) is a randomised interventional study sponsored by Trustees of Dartmouth College with National Cancer Institute (NCI). Its primary outcome is decisional conflict; it is funded by a National Cancer Institute R01 grant.
The registry record, read on 29 October 2026, gives its status as not yet recruiting, with an estimated 3,000 participants, a planned start in September 2027 and primary completion expected in July 2028.
Shares A mandatory decision aid before any multi-cancer blood test, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), National Cancer Institute (NIH), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), National Cancer Institute (NIH), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/